PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1988 December; 81(12): 691–697.
PMCID: PMC1291879

Essential aspects of the research problem in schizophrenia.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Egeland JA, Gerhard DS, Pauls DL, Sussex JN, Kidd KK, Allen CR, Hostetter AM, Housman DE. Bipolar affective disorders linked to DNA markers on chromosome 11. Nature. 325(6107):783–787. [PubMed]
  • St George-Hyslop PH, Tanzi RE, Polinsky RJ, Haines JL, Nee L, Watkins PC, Myers RH, Feldman RG, Pollen D, Drachman D, et al. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science. 1987 Feb 20;235(4791):885–890. [PubMed]
  • Buchsbaum MS, Ingvar DH, Kessler R, Waters RN, Cappelletti J, van Kammen DP, King AC, Johnson JL, Manning RG, Flynn RW, et al. Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry. 1982 Mar;39(3):251–259. [PubMed]
  • Farkas T, Wolf AP, Jaeger J, Brodie JD, Christman DR, Fowler JS. Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study. Arch Gen Psychiatry. 1984 Mar;41(3):293–300. [PubMed]
  • Ingvar DH, Franzén G. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand. 1974;50(4):425–462. [PubMed]
  • Bogerts B, Wurthmann C, Piroth HD. Hirnsubstanzdefizit mit paralimbischem und limbischem Schwerpunkt im CT Schizophrener. Nervenarzt. 1987 Feb;58(2):97–106. [PubMed]
  • Weinberger DR, DeLisi LE, Perman GP, Targum S, Wyatt RJ. Computed tomography in schizophreniform disorder and other acute psychiatric disorders. Arch Gen Psychiatry. 1982 Jul;39(7):778–783. [PubMed]
  • Bogerts B, Häntsch J, Herzer M. A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics. Biol Psychiatry. 1983 Sep;18(9):951–969. [PubMed]
  • Stevens JR. Neuropathology of schizophrenia. Arch Gen Psychiatry. 1982 Oct;39(10):1131–1139. [PubMed]
  • Nasrallah HA, McCalley-Whitters M, Bigelow LB, Rauscher FP. A histological study of the corpus callosum in chronic schizophrenia. Psychiatry Res. 1983 Apr;8(4):251–260. [PubMed]
  • Jakob H, Beckmann H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm. 1986;65(3-4):303–326. [PubMed]
  • KLAGES W. Frontale und diencephale Antriebsschwäche. Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr. 1954;191(5):365–387. [PubMed]
  • Reibaud M, Blanc G, Studler JM, Glowinski J, Tassin JP. Non-DA prefronto-cortical efferents modulate D1 receptors in the nucleus accumbens. Brain Res. 1984 Jul 2;305(1):43–50. [PubMed]
  • Roberts GW, Ferrier IN, Lee Y, Crow TJ, Johnstone EC, Owens DG, Bacarese-Hamilton AJ, McGregor G, O'Shaughnessey D, Polak JM, et al. Peptides, the limbic lobe and schizophrenia. Brain Res. 1983 Dec 12;288(1-2):199–211. [PubMed]
  • Liddle PF. Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychol Med. 1987 Feb;17(1):49–57. [PubMed]
  • Benes FM, Davidson J, Bird ED. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry. 1986 Jan;43(1):31–35. [PubMed]
  • Falkai P, Bogerts B. Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci. 1986;236(3):154–161. [PubMed]
  • Roberts GW, Colter N, Lofthouse R, Bogerts B, Zech M, Crow TJ. Gliosis in schizophrenia: a survey. Biol Psychiatry. 1986 Sep;21(11):1043–1050. [PubMed]
  • Gunne LM, Growdon J, Glaeser B. Oral dyskinesia in rats following brain lesions and neuroleptic drug administration. Psychopharmacology (Berl) 1982;77(2):134–139. [PubMed]
  • Whalley LJ, Christie JE, Brown S, Arbuthnott GW. Schneider's first-rank symptoms of schizophrenia. An association with increased growth hormone response to apomorphine. Arch Gen Psychiatry. 1984 Nov;41(11):1040–1043. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press